Saleena Subaiya, MD MSc is an Assistant Professor in the Department of Psychiatry at Columbia University Irving Medical Center (CUIMC), and is board certified in Emergency Medicine. They are the co-investigator on trials evaluating psilocybin, ketamine, and N, N-dimethyltryptamine as a treatment for individuals with neuropsychiatric PASC. They also are a co-investigator on a prospective cohort study evaluating ceremonial ayahuasca and its impact on depression, anxiety, and mindfulness in over 20 different countries. They have been a clinical facilitator for several NIH-funded trials evaluating ketamine as a treatment for substance use disorder.